The device, called Biolinq Shine, is indicated for people with Type 2 diabetes who don’t depend on insulin. Biolinq says its ...

AI tools like ChatGPT enable quick generation of written content for multiple uses. AI-generated art can be sold as NFTs or used in products like T-shirts. Building websites with AI can create income ...

The new vitamin D test, to be distributed from the Swiss-based company's Indianapolis hub, is the first such test using a ...

Heartflow disclosed the clearance alongside news that Cigna has become the second national insurer after UnitedHealthcare to ...

As the ability to treat more complex peripheral vascular lesions from a minimally invasive approach continues to advance, driven by the development of new technology and operator experience and ...

After launching a multi-campus phased rollout of the predictive insulin dosing software, Philadelphia-based Temple Health’s University Hospital has reduced hypoglycemia rates two- to threefold.   The ...

Batch mixing remains the predominant approach in industries where product diversity, regulatory oversight and recipe ...

Capitalism is often thought of as an economic system in which private actors own and control property in accord with their interests, and demand and supply freely set prices in markets in a way that ...

Biolinq announced today that it received FDA de novo clearance for its lead product, the Biolinq Shine wearable biosensor.

Patients want quick confirmations, simple forms, clear directions, and a fast way to ask a question—without downloading another app. Your staff wants fewer no-shows, shorter check-ins, and less ...